Levy Richard S — SEC Form 4 filings
SEC reporting owner CIK 1454983. 27 Form 4 filings on record with FilingPulse; latest filed 2026-08-04.
Transaction summary — filings shown
Covers all 27 filings on record, filed 2024-04-03 to 2026-08-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 40,000 shares, $127,600 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 37 legs across 5 filings — 35,182 shares, $13,443,952 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 57.
- Largest priced transaction: sale of 5,000 shares @ $350.00 ($1,750,000) in MADRIGAL PHARMACEUTICALS, INC., filed 2024-11-08.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Director | 11 | — | 37 legs · 35,182 sh · $13,443,952 | 24 |
| Protara Therapeutics, Inc. (TARA) | Director | 5 | 2 legs · 40,000 sh · $127,600 | — | 3 |
| Kiniksa Pharmaceuticals International, plc (KNSA) | Director | 8 | — | — | 27 |
| Kodiak Sciences Inc. (KOD) | Director | 3 | — | — | 3 |
Form 4 filings — Levy Richard S
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-04 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 403 · Grant/award (A): 403 (derivative) @ $0 · Option exercise (M): 403 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | Kodiak Sciences Inc. (KOD) | Grant/award (A): 17,731 (derivative) @ $0 | EDGAR |
| 2026-06-18 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Grant/award (A): 454 @ $0 · Grant/award (A): 766 (derivative) @ $0 | EDGAR |
| 2026-06-16 | 4 | Protara Therapeutics, Inc. (TARA) | Grant/award (A): 31,000 (derivative) @ $0 | EDGAR |
| 2026-06-02 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 2,799 · Grant/award (A): 12,158 (derivative) @ $0 · Grant/award (A): 2,026 (derivative) @ $0 · Option exercise (M): 2,799 (derivative) @ $0 | EDGAR |
| 2026-05-22 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Sale (S): 40 @ $506.68 · Sale (S): 320 @ $508.24 · Sale (S): 151 @ $510.36 · Sale (S): 610 @ $511.40 · Sale (S): 439 @ $512.50 · Sale (S): 40 @ $512.97 · +6 more | EDGAR |
| 2026-02-24 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Option exercise (M): 2,500 @ $7.36 · Option exercise (M): 2,500 (derivative) @ $0 | EDGAR |
| 2026-02-04 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 683 · Grant/award (A): 683 (derivative) @ $0 · Option exercise (M): 683 (derivative) @ $0 | EDGAR |
| 2026-01-26 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Option exercise (M): 4,000 @ $16.46 · Option exercise (M): 4,000 (derivative) @ $0 | EDGAR |
| 2025-11-14 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Option exercise (M): 2,500 @ $7.36 · Option exercise (M): 6,000 @ $16.46 · Sale (S): 146 @ $514.67 · Sale (S): 919 @ $515.64 · Sale (S): 645 @ $517.51 · Sale (S): 835 @ $518.53 · +12 more | EDGAR |
| 2025-07-03 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 1,101 · Grant/award (A): 1,101 (derivative) @ $0 · Option exercise (M): 1,101 (derivative) @ $0 | EDGAR |
| 2025-07-02 | 4 | Kodiak Sciences Inc. (KOD) | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2025-06-24 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Grant/award (A): 715 @ $0 · Grant/award (A): 1,290 (derivative) @ $0 | EDGAR |
| 2025-06-13 | 4 | Protara Therapeutics, Inc. (TARA) | Grant/award (A): 24,000 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 3,173 · Grant/award (A): 16,798 (derivative) @ $0 · Grant/award (A): 2,799 (derivative) @ $0 · Option exercise (M): 3,173 (derivative) @ $0 | EDGAR |
| 2025-05-19 | 4/A | Protara Therapeutics, Inc. (TARA) | Purchase (P): 20,000 @ $3.19 | EDGAR |
| 2025-05-16 | 4 | Protara Therapeutics, Inc. (TARA) | Purchase (P): 20,000 @ $3.19 | EDGAR |
| 2025-04-11 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Option exercise (M): 9,470 @ $65.06 · Option exercise (M): 9,470 (derivative) @ $0 | EDGAR |
| 2024-11-12 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 1,303 · Grant/award (A): 1,303 (derivative) @ $0 · Option exercise (M): 1,303 (derivative) @ $0 | EDGAR |
| 2024-11-08 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Option exercise (M): 5,000 @ $7.36 · Sale (S): 5,000 @ $350 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2024-11-05 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Option exercise (M): 5,000 @ $7.36 · Sale (S): 2,800 @ $300.10 · Sale (S): 1,100 @ $301.22 · Sale (S): 800 @ $302.25 · Sale (S): 300 @ $304.29 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2024-07-01 | 4 | Kodiak Sciences Inc. (KOD) | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2024-06-27 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Grant/award (A): 714 @ $0 · Grant/award (A): 1,105 (derivative) @ $0 | EDGAR |
| 2024-06-10 | 4 | Protara Therapeutics, Inc. (TARA) | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Kiniksa Pharmaceuticals, Ltd. (KNSA) | Option exercise (M): 4,373 · Grant/award (A): 19,040 (derivative) @ $0 · Grant/award (A): 3,173 (derivative) @ $0 · Option exercise (M): 4,373 (derivative) @ $0 | EDGAR |
| 2024-05-07 | 4 | Kiniksa Pharmaceuticals, Ltd. (KNSA) | Option exercise (M): 747 · Grant/award (A): 747 (derivative) @ $0 · Option exercise (M): 747 (derivative) @ $0 | EDGAR |
| 2024-04-03 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Option exercise (M): 5,000 @ $7.36 · Option exercise (M): 6,000 @ $111.06 · Sale (S): 4,387 @ $255.90 · Sale (S): 3,900 @ $256.88 · Sale (S): 1,600 @ $257.93 · Sale (S): 100 @ $259.07 · +4 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1454983 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →